In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp.

Telavancin is a new semisynthetic glycopeptide anti-infective with multiple mechanisms of action, including inhibition of bacterial membrane phospholipid synthesis and inhibition of bacterial cell wall synthesis. We determined the in vitro activities of telavancin, vancomycin, daptomycin, linezolid,...

Szczegółowa specyfikacja

Zapisane w:

Opis bibliograficzny
Wydane w:	Antimicrob Agents Chemother
Główni autorzy:	Goldstein, Ellie J. C., Citron, Diane M., Merriam, C. Vreni, Warren, Yumi A., Tyrrell, Kerin L., Fernandez, Helen T.
Format:	Artigo
Język:	Inglês
Wydane:	American Society for Microbiology (ASM) 2004
Hasła przedmiotowe:	Susceptibility
Dostęp online:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC415607/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15155214/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/AAC.48.6.2149-2152.2004
Etykiety:	Dodaj etykietę Nie ma etykietki, Dołącz pierwszą etykiete!

In Vitro Activities of the New Semisynthetic Glycopeptide Telavancin (TD-6424), Vancomycin, Daptomycin, Linezolid, and Four Comparator Agents against Anaerobic Gram-Positive Species and Corynebacterium spp.

Podobne zapisy